YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients
© 2024. The Author(s), under exclusive licence to Springer Nature B.V..
BACKGROUND: Vascular calcification (VC) is highly prevalent and predicts cardiovascular mortality in dialysis patients. The mechanisms are still unclear. Inflammation is a well-known inducer of VC. YKL-40 has been suggested as a novel biomarker of inflammation and has been demonstrated to be associated with cardiovascular mortality in hemodialysis patients. This study aims to evaluate the relationship between serum YKL-40 and VC in hemodialysis (HD) patients.
METHODS: A total of 109 HD patients and 31 healthy controls were enrolled in the study from September 2014 to December 2014. We evaluated the abdominal aortic calcification (AAC) score by plain X-ray films of the abdomen and measured serum YKL-40 concentrations using enzyme-linked immunosorbent assay. We also examined the relationship between YKL-40 levels and AAC scores in HD patients.
RESULTS: Serum YKL-40 levels in HD patients were significantly higher than those in healthy controls [199.8 (144.8, 288.7) vs. 71.9 (52.8, 89.3) ng/ml; P < 0.001]. There was a tendency that YKL-40 levels in diabetic hemodialysis patients were higher than those in nondiabetic patients [217.8 (155.3, 335.8) vs. 192.9 (135.9, 274.4) ng/ml; P = 0.093]. A significant positive correlation was found between serum YKL-40 level and AAC score in these patients (r = 0.410, P = 0.003). Multiple regression analysis showed that Ln(YKL-40) was independently associated with AAC score in HD patients (P = 0.044).
CONCLUSION: This study showed high serum YKL-40 concentrations in chronic HD patients and that YKL-40 was independently associated with increased AAC in hemodialysis patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
International urology and nephrology - (2024) vom: 16. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bi, Shu-Hong [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hemodialysis |
---|
Anmerkungen: |
Date Revised 17.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1007/s11255-024-03986-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369829506 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369829506 | ||
003 | DE-627 | ||
005 | 20240317233514.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240317s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11255-024-03986-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1333.xml |
035 | |a (DE-627)NLM369829506 | ||
035 | |a (NLM)38493270 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bi, Shu-Hong |e verfasserin |4 aut | |
245 | 1 | 0 | |a YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 17.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024. The Author(s), under exclusive licence to Springer Nature B.V. | ||
520 | |a BACKGROUND: Vascular calcification (VC) is highly prevalent and predicts cardiovascular mortality in dialysis patients. The mechanisms are still unclear. Inflammation is a well-known inducer of VC. YKL-40 has been suggested as a novel biomarker of inflammation and has been demonstrated to be associated with cardiovascular mortality in hemodialysis patients. This study aims to evaluate the relationship between serum YKL-40 and VC in hemodialysis (HD) patients | ||
520 | |a METHODS: A total of 109 HD patients and 31 healthy controls were enrolled in the study from September 2014 to December 2014. We evaluated the abdominal aortic calcification (AAC) score by plain X-ray films of the abdomen and measured serum YKL-40 concentrations using enzyme-linked immunosorbent assay. We also examined the relationship between YKL-40 levels and AAC scores in HD patients | ||
520 | |a RESULTS: Serum YKL-40 levels in HD patients were significantly higher than those in healthy controls [199.8 (144.8, 288.7) vs. 71.9 (52.8, 89.3) ng/ml; P < 0.001]. There was a tendency that YKL-40 levels in diabetic hemodialysis patients were higher than those in nondiabetic patients [217.8 (155.3, 335.8) vs. 192.9 (135.9, 274.4) ng/ml; P = 0.093]. A significant positive correlation was found between serum YKL-40 level and AAC score in these patients (r = 0.410, P = 0.003). Multiple regression analysis showed that Ln(YKL-40) was independently associated with AAC score in HD patients (P = 0.044) | ||
520 | |a CONCLUSION: This study showed high serum YKL-40 concentrations in chronic HD patients and that YKL-40 was independently associated with increased AAC in hemodialysis patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Hemodialysis | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Vascular calcification | |
650 | 4 | |a YKL-40 | |
700 | 1 | |a Su, Chunyan |e verfasserin |4 aut | |
700 | 1 | |a A, La-Ta |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yue |e verfasserin |4 aut | |
700 | 1 | |a He, Lian |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Ai-Hua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International urology and nephrology |d 1971 |g (2024) vom: 16. März |w (DE-627)NLM000017531 |x 1573-2584 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:16 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11255-024-03986-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 16 |c 03 |